CEO SUMMARY: On March 13, 2007, the Food and Drug Administration sent a warning letter to Abbott Laboratories’ Chairman and CEO, Miles D. White. The letter identified nine quality system violations and requested a satisfactory response by August 15, 2007. The warning letter is based on deficiencies identified by FDA inspectors at Abbott’s manufacturing facility […]
FDA Sends Warning Letter to Abbott Laboratories
Products manufactured in Irving, Texas, have not met FDA’s CGMP guidelines
- By Robert Michel
- > From the Volume XIV No. 6 - April 23, 2007 Issue
- Tags: analyzer, analyzers, automated chemistry, chemistry analyzer, chemistry analyzers, clinical lab, Clinical Laboratory, clinical laboratory industry, Food and Drug Administration (FDA), laboratories, laboratory industry, laboratory manager, laboratory managers, pathologists, quality assurance, quality assurance system, quality system, the clinical laboratory, the laboratory
